Trials / Completed
CompletedNCT01542866
A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)
A 16 Week Evaluation of the Novartis Health Management Tool in Assessing Self-test Visual Function in Patients With AMD Treated With Ranibizumab
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a prospective pilot study to evaluate the usability and applicability of a self monitoring test of visual function with the handheld Health Management Tool (HMT) to remotely monitor neovascular Age Related Macular Degeneration (AMD) to detect a potential change in disease status.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Health Management Tool (HMT) | Mobile computing platform (ie HMT) which allows subjects to perform home monitoring tests |
Timeline
- Start date
- 2011-01-11
- Primary completion
- 2011-11-30
- Completion
- 2011-11-30
- First posted
- 2012-03-02
- Last updated
- 2018-07-12
Locations
23 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01542866. Inclusion in this directory is not an endorsement.